MedPath

a Randomized Controlled Trial of the Intake of Organic and Inorganic Phosphate in Peritoneal Dialysis Patients

Not Applicable
Conditions
Chronic Kidney Disease Requiring Chronic Dialysis
Interventions
Other: Diet containing inorganic phosphate
Other: Diet containing organic phosphate
Registration Number
NCT04600193
Lead Sponsor
University of Copenhagen
Brief Summary

Hyperphosphatemia is a common problem among patientens suffering from chronic kidney disease. Hyperphosphatemia is associated with increased risk of cardiovascular diseases. One of the treatments are through the diet, where patients are instructed ind reducing their daily intake of phosphate. But since phosphate exists in both organic and inorganic forms in the diet, this leads to several problems. Informations of the bioavability and furthermore the effect of plasma koncentrations of phosphate are lacking for both forms of phosphate.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
21
Inclusion Criteria
  • Patients > 18 years
  • Competent
  • The patient should be able to take a sample of p-fluid and urine by himself
  • Chronic peritoneal dialysis
  • Reads and understand danish
  • Has been informed written and oraly about the study and signed informed consent
  • P-phosphate koncentrations 0,7-2,0 .mol/l
  • P - ioniset calcium 1,1-1,4 mmol/l
Exclusion Criteria
  • Pregnant or breast-feeding
  • Terminal patients
  • If the experience acute infections or other acute situations they will be excluded from the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Phosphate modified diet with inorganic phosphateDiet containing inorganic phosphate-
Phosphate modified diet with organic phosphateDiet containing organic phosphate-
Primary Outcome Measures
NameTimeMethod
Plasma levels of phosphatesix days
Secondary Outcome Measures
NameTimeMethod
Changes in p-potassiumsix days
Koncentration of phosphate in urinesix days
Changes in p-sodiumsix days
Changes in p-magnesiumsix days
changes in p-calciumsix days
Koncentration of phosphate in peritoneal dialysis fluidsix days
Changes in p-phosphatesix days
changes in p-PTHsix days
Changes in p-FGF23six days

Trial Locations

Locations (1)

Herlev Hospital

🇩🇰

Herlev, Denmark

© Copyright 2025. All Rights Reserved by MedPath